Top compounds associated with response to CLDN16


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.24 0.0003
mRNA Docetaxel gCSI pan-cancer AAC -0.22 0.0008
mRNA Irinotecan CCLE pan-cancer AAC -0.16 0.01
mRNA MG-132 CTRPv2 pan-cancer AAC -0.16 0.01
mRNA Vorinostat gCSI pan-cancer AAC -0.16 0.01
mRNA paclitaxel CCLE pan-cancer AAC -0.16 0.003
mRNA 17-AAG CCLE pan-cancer AAC -0.15 0.005
mRNA thapsigargin gCSI pan-cancer AAC -0.14 0.05
mRNA Doxorubicin gCSI pan-cancer AAC -0.13 0.04
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.13 0.0002
Download CSV